Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978638 · ClinicalTrials.gov registry record · NA
Electrical Stimulation for Continence After Spinal Cord Injury
A NA study of Spinal Cord Injury and Neurogenic Bladder, sponsored by Palo Alto Veterans Institute for Research.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 4
- Study locations
NCT02978638 is a NA study of Spinal Cord Injury and Neurogenic Bladder that is active but no longer recruiting, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 10 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT02978638, a NA study of Spinal Cord Injury and Neurogenic Bladder, is active but no longer recruiting, sponsored by Palo Alto Veterans Institute for Research.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study aims to improve continence and voiding of patients with spinal cord injury using electrical stimulation. The Finetech Vocare Bladder System is an implantable sacral nerve stimulator for improving bladder and bowel function in patients with spinal cord injury (SCI). It has been commercially available in Britain and other countries since 1982, and has been used in thousands of patients with SCI to improve bladder, bowel and sexual function. It received FDA approval in 1998 under Humanitarian Device Exemption H980005 and H980008 for providing urination on demand and to aid in bowel evacuation. Electrical stimulation to produce bladder contraction and improve bladder voiding after spinal cord injury has usually been combined with cutting of sensory nerves to reduce reflex contraction of the bladder, which improves continence. However, cutting these nerves has undesirable side effects. This study will not cut any sensory nerve. This study is testing the use of the stimulator for inhibiting bladder contraction by stimulating sensory nerves to improve continence after spinal cord injury, and for blocking sphincter contraction to improve voiding.
Conditions Studied
Interventions
- DEVICE Finetech Vocare Bladder System
Study Locations (4)
California
- Palo Alto Veterans Institute for Research - Palo Alto
- Santa Clara Valley Medical Center - San Jose
New Mexico
- University of New Mexico - Albuquerque
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-09 |
| Est. Completion | 2025-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02978638
The ClinicalTrials.gov registry entry for NCT02978638 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (88% lower). The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Finetech Vocare Bladder System is the first listed.
NCT02978638 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, New Mexico, Ohio.
Frequently Asked Questions
What is clinical trial NCT02978638 about?
NCT02978638 is a clinical study titled "Electrical Stimulation for Continence After Spinal Cord Injury". This study aims to improve continence and voiding of patients with spinal cord injury using electrical stimulation. The Finetech Vocare Bladder System is an implantable sacral nerve stimulator for improving bladder and bowel function in patients with spinal cord injury (SCI). It has been commercial...
What is the current status of trial NCT02978638?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2014-09. Estimated completion is 2025-09-28.
What conditions does trial NCT02978638 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Neurogenic Bladder, Incontinence.
What interventions are being tested in trial NCT02978638?
The interventions under investigation include: Finetech Vocare Bladder System (DEVICE).
Who is sponsoring clinical trial NCT02978638?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02978638 being conducted?
This trial has 4 study locations across California, New Mexico, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.